Clinical Trials in Emerging Markets

Addressing the Global Disparity in Access to Clinical Trials

Most clinical trials are sponsored and conducted in the US and EU. 90% of the world’s population is minimally engaged or cannot access life-saving therapies in clinical trials. Even within the US and EU, about 95% of the population lives far away from the medical research hospitals where clinical trials are conducted and hence have been underserved. 

Jeeva to committed to enabling clinical trial sponsors and investigators access to all patients irrespective of their geographic location, socio-economic status, gender, race, or ethnicity.

Global Disparity in Access to Clinical Trials - Emerging Market
"Clinical Studies Sponsored in Emerging Markets"

Challenges in Clinical Studies Sponsored in Emerging Markets

Clinical studies sponsored in emerging markets are extremely cost-conscious and lack the level of quality training and regulatory compliance expected by regulators in the US and EU.  

Jeeva eClinical Cloud supports these emerging market clinical trials, patient concierge, or clinical studies with the same high-quality standards, data security, privacy, and regulatory compliance but with the most affordable, cost-effective solution to help overcome these barriers. 

Benefits to Clinical Trials in Emerging Markets

We Interviewed Hundreds Of Patients, Advocates, And Foundation Leaders - Patient Groups

Compliance Programs Supported

Client Testimonials

Ready to Explore Jeeva eClinical Cloud for Your Study?

Jeeva’s eClinical Cloud modules and packages are designed to accommodate various diseases, devices, and trial operations, allowing for flexibility and customization to fit the needs of patients. Get in touch with us for a 30-minute call where we can assess your requirements and provide guidance on any technology or protocol challenges you may encounter, ensuring an informed decision-making process.